As of 2025-04-26, the Intrinsic Value of Neximmune Inc (NEXI) is -2,914,540.00 USD. This NEXI valuation is based on the model Peter Lynch Fair Value. With the current market price of 3.93 USD, the upside of Neximmune Inc is -74,161,425.00%.
Based on its market price of 3.93 USD and our intrinsic valuation, Neximmune Inc (NEXI) is overvalued by 74,161,425.00%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -2,914,540.00 - -2,914,540.00 | -2,914,540.00 | -74,161,425.00% |
| P/E | (8,685,340.55) - (18,011,880.74) | (14,077,246.60) | -358199759.0% |
| DDM - Stable | (5,292,481.96) - (22,133,564.55) | (13,713,025.53) | -348932047.3% |
| DDM - Multi | (14,805,134.57) - (49,288,982.61) | (22,906,471.77) | -582861977.1% |
| Market Cap (mil) | 0.00 |
| Beta | 1.22 |
| Outstanding shares (mil) | 0.00 |
| Enterprise Value (mil) | -2.42 |
| Market risk premium | 4.60% |
| Cost of Equity | 9.04% |
| Cost of Debt | 5.00% |
| WACC | 6.35% |